<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1824">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01667224</url>
  </required_header>
  <id_info>
    <org_study_id>TgBio-TG1022-001</org_study_id>
    <nct_id>NCT01667224</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Actiponin on Antiobesity in Obese Korean Subjects.</brief_title>
  <official_title>Actiponin Supplementation Reduces Abdominal Fat Area, Weight, Body Fat Mass and BMI in Obese Korean Subjects.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chonbuk National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chonbuk National University Hospital</source>
  <oversight_info>
    <authority>Korea: Food and Drug Administration</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Obesity is a major health issue worldwide; there is a constant raise in obesity related
      death each year. In vitro and animal studies elucidated Actiponin as a novel anti-obesity
      agent. However, the efficacy and safety of Actiponin supplementation on body weight
      regulation in humans are lacking.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary aim of the study was to investigate the effect of Actiponin in Korean subjects
      on body weight and fat loss along with changes in metabolic markers based on 12 week,
      randomized, double-blind, placebo-controlled clinical trial.

      Eighty obesity subjects with BMI &gt; 25kg/m2 and waist-hip ratio (WHR) ≥ 0.90 for men and ≥
      0.85 for women were randomly divided into either Actiponin (n=40, 450mg/day) or placebo
      group (n=40, 450mg/day) for 12weeks.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2009</start_date>
  <completion_date type="Actual">October 2010</completion_date>
  <primary_completion_date type="Actual">August 2010</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Changes in Body Fat Mass.</measure>
    <time_frame>12week</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Body fat mass was measured in study visit 1(0 week), visit 2(4 week), visit 3(8 week) and visit 4(12 week).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in Abdominal Total Fat Area.</measure>
    <time_frame>12 week</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Abdominal total fat area was measured in study visit 1(0 week) and visit 4(12 week).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Body Weight.</measure>
    <time_frame>12 week</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Body weight was measured in study visit 1(0 week), visit 2(4 week), visit 3(8 week) and visit 4(12 week).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Body Mss Index(BMI)</measure>
    <time_frame>12 week</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>BMI was measured in study visit 1 (0 week), visit 2 (4 week), visit 3 (8 week) and visit 4 (12 week).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Actiponin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Actiponin(extract of Gynostema pentaphyllum, 450mg/day) for 12weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo(450mg/day) for 12weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Actiponin</intervention_name>
    <description>The dried leaves of G. pentaphyllum leaves were extracted with 50% ethanol and filtered; the filtrate was concentrated under high pressure and high temperature. Damulin An and B, analytical marker of Actiponin, exist more 2.49% and 1.06% respectively in raw material.</description>
    <arm_group_label>Actiponin</arm_group_label>
    <other_name>Extract of Gynostemma pentaphyllum(450mg/day)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Amount and calorie of placebo are same with Actiponin.</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Placebo(450mg/day)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI ≥ 25kg/m2 and WHR ≥ 0.90(men), WHR ≥ 0.85(women)

        Exclusion Criteria:

          -  Significant variation in weight(more 10%) in the past 3 months

          -  Cardiovascular disease, e.g. arrhythmia, heart failure, myocardial infarction, and
             patient with pacemaker

          -  History of disease that could interfere with the test products or impede theire
             absorption, such as gastrointestinal disease or gastrointestinal surgery

          -  Participation in any other clinical trials within past 2 months

          -  Abdominal hepatic liver function

          -  Renal disease, e.g. acute/chronic renal failure, nephritic syndrome

          -  Used antipsychosis drugs therapy within past 2 months

          -  Laboratory test, medical or psychological conditions deemed by the investigators to
             interfere with successful participation in the study

          -  Pregnancy or breast feeding

          -  History of alcohol or substance abuse

          -  Allergic or hypersensitive to any of the ingredients in the test products
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Soo-Wan Chae, Ph.D, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Chonbuk National University Hospital</affiliation>
  </overall_official>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 16, 2014</lastchanged_date>
  <firstreceived_date>August 14, 2012</firstreceived_date>
  <firstreceived_results_date>March 16, 2014</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chonbuk National University Hospital</investigator_affiliation>
    <investigator_full_name>Soo-Wan Chae</investigator_full_name>
    <investigator_title>Clinical Trial Center for Functional Foods</investigator_title>
  </responsible_party>
  <keyword>Actiponin</keyword>
  <keyword>Obesity</keyword>
  <keyword>Abdominal fat</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>

  <clinical_results>

    <participant_flow>
      <recruitment_details>The study subjects were recruited from Clinical Trial Center for Functional Food in Chonbuk National University Hospital during the 2009. Only those subjects who were obese[both BMI≥25kg/m2 and WHR≥0.90(men), WHR≥0.85(women)] and were not diagnosed with any disease were included in this study.</recruitment_details>
      <pre_assignment_details>Among the 105 subjets screened, 25 subjects had anthropometric and/or laboratory tests results that were in the exclusion criteria category, hence they were excluded from the study.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Actiponin</title>
          <description>Actiponin(extract of Gynostema pentaphyllum, 450mg/day) for 12weeks
Actiponin : The dried leaves of G. pentaphyllum leaves were extracted with 50% ethanol and filtered; the filtrate was concentrated under high pressure and high temperature. Damulin An and B, analytical marker of Actiponin, exist more 2.49% and 1.06% respectively in raw material.</description>
        </group>
        <group group_id="P2">
          <title>Placebo</title>
          <description>Placebo(450mg/day) for 12weeks
Placebo : Amount and calorie of placebo are same with Actiponin.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="40"/>
                <participants group_id="P2" count="40"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="36"/>
                <participants group_id="P2" count="38"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Actiponin</title>
          <description>Actiponin(extract of Gynostema pentaphyllum, 450mg/day) for 12weeks
Actiponin : The dried leaves of G. pentaphyllum leaves were extracted with 50% ethanol and filtered; the filtrate was concentrated under high pressure and high temperature. Damulin An and B, analytical marker of Actiponin, exist more 2.49% and 1.06% respectively in raw material.</description>
        </group>
        <group group_id="B2">
          <title>Placebo</title>
          <description>Placebo(450mg/day) for 12weeks
Placebo : Amount and calorie of placebo are same with Actiponin.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="40"/>
                <measurement group_id="B2" value="40"/>
                <measurement group_id="B3" value="80"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>&lt;=18 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Between 18 and 65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="40"/>
                <measurement group_id="B2" value="40"/>
                <measurement group_id="B3" value="80"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>&gt;=65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="40.10" spread="9.67"/>
                <measurement group_id="B2" value="40.05" spread="11.58"/>
                <measurement group_id="B3" value="40.08" spread="10.60"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="18"/>
                <measurement group_id="B2" value="30"/>
                <measurement group_id="B3" value="48"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="22"/>
                <measurement group_id="B2" value="10"/>
                <measurement group_id="B3" value="32"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Korea, Republic of</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="40"/>
                <measurement group_id="B2" value="40"/>
                <measurement group_id="B3" value="80"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Changes in Body Fat Mass.</title>
        <description>Body fat mass was measured in study visit 1(0 week), visit 2(4 week), visit 3(8 week) and visit 4(12 week).</description>
        <time_frame>12week</time_frame>
        <safety_issue>Yes</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Actiponin</title>
            <description>Actiponin(extract of Gynostema pentaphyllum, 450mg/day) for 12weeks
Actiponin : The dried leaves of G. pentaphyllum leaves were extracted with 50% ethanol and filtered; the filtrate was concentrated under high pressure and high temperature. Damulin An and B, analytical marker of Actiponin, exist more 2.49% and 1.06% respectively in raw material.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo(450mg/day) for 12weeks
Placebo : Amount and calorie of placebo are same with Actiponin.</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="40"/>
                  <measurement group_id="O2" value="40"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Changes in Body Fat Mass.</title>
            <description>Body fat mass was measured in study visit 1(0 week), visit 2(4 week), visit 3(8 week) and visit 4(12 week).</description>
            <units>kg</units>
            <param>Mean</param>
            <dispersion>Standard Error</dispersion>
            <category_list>
              <category>
                <sub_title>Pre</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="27.80" spread="0.19"/>
                  <measurement group_id="O2" value="27.55" spread="0.20"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Post</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="21.40" spread="0.60"/>
                  <measurement group_id="O2" value="23.32" spread="0.62"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Data are present as the mean±S.E. to detect a 0.3kg(S.D.=0.6kg) difference in body weight between groups with 80% power and a two-tailed α-value of 0.05.</groups_desc>
            <non_inferiority>Yes</non_inferiority>
            <non_inferiority_desc>Data are present as the mean±S.E. to detect a 0.3kg(S.D.=0.6kg) difference in body weight between groups with 80% power and a two-tailed α-value of 0.05.</non_inferiority_desc>
            <p_value>&lt;0.05</p_value>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Changes in Abdominal Total Fat Area.</title>
        <description>Abdominal total fat area was measured in study visit 1(0 week) and visit 4(12 week).</description>
        <time_frame>12 week</time_frame>
        <safety_issue>Yes</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Actiponin</title>
            <description>Actiponin(extract of Gynostema pentaphyllum, 450mg/day) for 12weeks
Actiponin : The dried leaves of G. pentaphyllum leaves were extracted with 50% ethanol and filtered; the filtrate was concentrated under high pressure and high temperature. Damulin An and B, analytical marker of Actiponin, exist more 2.49% and 1.06% respectively in raw material.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo(450mg/day) for 12weeks
Placebo : Amount and calorie of placebo are same with Actiponin.</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="40"/>
                  <measurement group_id="O2" value="40"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Changes in Abdominal Total Fat Area.</title>
            <description>Abdominal total fat area was measured in study visit 1(0 week) and visit 4(12 week).</description>
            <units>cm2</units>
            <param>Mean</param>
            <dispersion>Standard Error</dispersion>
            <category_list>
              <category>
                <sub_title>Pre</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="332.24" spread="10.65"/>
                  <measurement group_id="O2" value="335.36" spread="7.24"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Post</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="311.35" spread="9.04"/>
                  <measurement group_id="O2" value="333.05" spread="8.36"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Data are present as the mean±S.D. to detect a 0.3kg(S.E.=0.6kg) difference in body weight between groups with 80% power and a two-tailed α-value of 0.05.</groups_desc>
            <non_inferiority>Yes</non_inferiority>
            <non_inferiority_desc>Data are present as the mean±S.D. to detect a 0.3kg(S.E.=0.6kg) difference in body weight between groups with 80% power and a two-tailed α-value of 0.05.</non_inferiority_desc>
            <p_value>&lt;0.05</p_value>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Changes in Body Weight.</title>
        <description>Body weight was measured in study visit 1(0 week), visit 2(4 week), visit 3(8 week) and visit 4(12 week).</description>
        <time_frame>12 week</time_frame>
        <safety_issue>Yes</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Actiponin</title>
            <description>Actiponin(extract of Gynostema pentaphyllum, 450mg/day) for 12weeks
Actiponin : The dried leaves of G. pentaphyllum leaves were extracted with 50% ethanol and filtered; the filtrate was concentrated under high pressure and high temperature. Damulin An and B, analytical marker of Actiponin, exist more 2.49% and 1.06% respectively in raw material.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo(450mg/day) for 12weeks
Placebo : Amount and calorie of placebo are same with Actiponin.</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="40"/>
                  <measurement group_id="O2" value="40"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Changes in Body Weight.</title>
            <description>Body weight was measured in study visit 1(0 week), visit 2(4 week), visit 3(8 week) and visit 4(12 week).</description>
            <units>kg</units>
            <param>Mean</param>
            <dispersion>Standard Error</dispersion>
            <category_list>
              <category>
                <sub_title>Pre</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="76.56" spread="1.31"/>
                  <measurement group_id="O2" value="73.41" spread="1.55"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Post</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="75.21" spread="1.37"/>
                  <measurement group_id="O2" value="73.33" spread="1.65"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Data are present as the mean±S.D. to detect a 0.3kg(S.E.=0.6kg) difference in body weight between groups with 80% power and a two-tailed α-value of 0.05.</groups_desc>
            <non_inferiority>Yes</non_inferiority>
            <non_inferiority_desc>Data are present as the mean±S.D. to detect a 0.3kg(S.E.=0.6kg) difference in body weight between groups with 80% power and a two-tailed α-value of 0.05.</non_inferiority_desc>
            <p_value>&lt;0.05</p_value>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Changes in Body Mss Index(BMI)</title>
        <description>BMI was measured in study visit 1 (0 week), visit 2 (4 week), visit 3 (8 week) and visit 4 (12 week).</description>
        <time_frame>12 week</time_frame>
        <safety_issue>Yes</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Actiponin(450mg/Day) for 12week</title>
            <description>Actiponin : The dried leaves of G. pentaphyllum leaves were extracted with 50% ethanol and filtered; the filtrate was concentrated under high pressure and high temperature. Damulin An and B, analytical marker of Actiponin, exist more 2.49% and 1.06% respectively in raw material.</description>
          </group>
          <group group_id="O2">
            <title>Placebo (450mg/Day) for 12 Week</title>
            <description>Placebo: Amount and calorie of placebo are same with Actiponin</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="40"/>
                  <measurement group_id="O2" value="40"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Changes in Body Mss Index(BMI)</title>
            <description>BMI was measured in study visit 1 (0 week), visit 2 (4 week), visit 3 (8 week) and visit 4 (12 week).</description>
            <units>kg/m2</units>
            <param>Mean</param>
            <dispersion>Standard Error</dispersion>
            <category_list>
              <category>
                <sub_title>Pre</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="27.80" spread="1.21"/>
                  <measurement group_id="O2" value="27.55" spread="1.27"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>Post</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="27.31" spread="1.24"/>
                  <measurement group_id="O2" value="27.55" spread="1.54"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Data are present as the mean±S.E. to detect a 0.3kg(S.D.=0.60kg) difference in body weight between groups with 80% power and a two-tailed α-value of 0.05.</groups_desc>
            <non_inferiority>Yes</non_inferiority>
            <non_inferiority_desc>Data are present as the mean±S.E. to detect a 0.3kg(S.D.=0.60kg) difference in body weight between groups with 80% power and a two-tailed α-value of 0.05.</non_inferiority_desc>
            <p_value>&lt;0.05</p_value>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>12 week</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Actiponin</title>
          <description>Actiponin(extract of Gynostema pentaphyllum, 450mg/day) for 12weeks
Actiponin : The dried leaves of G. pentaphyllum leaves were extracted with 50% ethanol and filtered; the filtrate was concentrated under high pressure and high temperature. Damulin An and B, analytical marker of Actiponin, exist more 2.49% and 1.06% respectively in raw material.</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>Placebo(450mg/day) for 12weeks
Placebo : Amount and calorie of placebo are same with Actiponin.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Soo-Wan Chae</name_or_title>
      <organization>Clinical Trial Center for Functional Food in Chonbuk National University Hospital</organization>
      <phone>82-63-250-2348</phone>
      <email>soowan@jbnu.ac.kr</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
